Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.
about
Meta-regression analyses, meta-analyses, and trial sequential analyses of the effects of supplementation with beta-carotene, vitamin A, and vitamin E singly or in different combinations on all-cause mortality: do we have evidence for lack of harm?Helicobacter pylori eradication for the prevention of gastric neoplasiaAntioxidant supplements for preventing gastrointestinal cancersChinese herbal medicine alone or combined with vitamins for gastric precancerous lesionsAntioxidant supplements for preventing gastrointestinal cancersRole of bacteria in oncogenesisNew advances in targeted gastric cancer treatmentHelicobacter pylori Infection Synergistic with IL-1β Gene Polymorphisms Potentially Contributes to the Carcinogenesis of Gastric CancerGastric Cancer: How Can We Reduce the Incidence of this Disease?Non-pharmacological treatment of Helicobacter pyloriDiagnosis and management of gastric dysplasiaHelicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillanceMolecular cancer prevention: Current status and future directionsExploring alternative treatments for Helicobacter pylori infectionThe diagnosis and treatment of Helicobacter pylori infection in Arctic regions with a high prevalence of infection: Expert CommentaryGastric cancer: prevention, screening and early diagnosisHistological changes of gastric mucosa after Helicobacter pylori eradication: a systematic review and meta-analysisNotes from the field: "green" chemoprevention as frugal medicineDiagnosis and management of high risk group for gastric cancerClinical epidemiology of gastric cancerCancer prevention and control: alarming challenges in ChinaThe problem of Helicobacter pylori resistance to antibiotics: a systematic review in Latin AmericaScreening and treating Helicobacter pylori infection for gastric cancer prevention on the population level.Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade PortuPrevalence of A2143G mutation of H. pylori-23S rRNA in Chinese subjects with and without clarithromycin use history.Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trialsHelicobacter pylori antibody responses in association with eradication outcome and recurrence: a population-based intervention trial with 7.3-year follow-up in China.The association between vacA or cagA status and eradication outcome of Helicobacter pylori infection: A meta-analysis.Effect of Helicobacter pylori eradication on gastric carcinogenesis.Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroupsA systematic review and meta-analysis of the role of Helicobacter pylori eradication in preventing gastric cancer.Eradication of H pylori infection in a rural population: one-day quadruple therapy versus 7-day triple therapy.At the bedside: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancer.Pathology of gastric intestinal metaplasia: clinical implications.Effects of Helicobacter pylori infection and smoking on gastric cancer incidence in China: a population-level analysis of trends and projections.Effects of selenium supplements on cancer prevention: meta-analysis of randomized controlled trials.Management of Helicobacter pylori infection in Latin America: a Delphi technique-based consensusCost-effectiveness of treatment and endoscopic surveillance of precancerous lesions to prevent gastric cancer.Prevention of Gastric Cancer: When is Treatment of Helicobacter Pylori Warranted?Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancer.
P2860
Q21090716-6A299337-D129-4786-A886-541C4A26FF92Q24186365-FC1102C2-93B1-40C5-B267-011CFEC6A213Q24242191-6D8F68FC-FCBD-427A-B06C-19F7276EC561Q24243598-00553E4C-88A3-4FBC-9284-B1A97DF8B140Q24245704-F5777713-D3B3-432C-B726-7B7CFF18159EQ24633180-C0BA0E51-7C6E-40C4-9B53-3086DD8EB407Q26738548-55E2938E-C575-4575-AE3B-EA61A2C9B78DQ26748588-61BE6C72-0691-49BA-B44C-853F856874CBQ26749352-C7F90F97-9BD6-4999-B5E3-D575C4C0AD9AQ26751181-8A5C8ADF-85FE-42CA-A316-181B7D07BDFBQ26765128-ECA56B3B-EF63-4B5F-BA46-FACD85D9213EQ26774447-47EEB0C5-BAD9-4E7C-B980-2D1329F6FF94Q26797207-3DB35714-0609-4CDD-8499-0D6DD2512082Q26828017-B5765656-FFA3-48DB-9CEB-24AF5DB4761CQ26852409-830B3351-96D2-4290-8B49-6F632C7C1250Q26860418-1C04D5C8-5558-42F1-8FB9-AE57EF7C851FQ26864431-847E17B8-2DE7-44DB-87AF-35FC85104FE2Q27021094-A48B89C6-5AE1-43D7-A8C5-984737D162BFQ28084323-9D2534AB-DE02-42BE-81C6-AEE696DAA276Q28085054-D97F10FB-2DBF-46B5-925A-4747B09286B7Q28396786-56C615EF-FCAA-4447-8AD9-72C461EE2D15Q30217199-6E6B4D2F-F894-45C8-8883-9281FB55AF91Q30239019-630816CD-CE8B-4ACB-9942-7026200BBD05Q30426539-E9CC64D4-5CF4-4EFE-BDDB-FCC6E9F1F073Q33338257-A3EAB244-23D3-4734-ADB0-FDE2F76CC0BAQ33636554-D1FEDE4B-3F79-4571-AF80-A6A991FCFAD0Q33649953-B688170E-D3A1-42BC-9BCC-E55D10F0ECD6Q33663880-565195AA-CE01-42EE-B1A8-AD4422A11A82Q33708748-359928E1-1E4C-4578-BAD8-FDBB2BB6EC3FQ33792622-997E318A-D62D-4D49-A25E-9E0297C5259AQ33822961-904C2153-2C25-46E7-9F3A-661C66478838Q33868331-8745CDD1-7CE1-4C41-9347-B4F559F7B5F1Q33911623-5DF526F7-8FB4-4AB1-967B-F7833EAE335CQ33954445-5D8929E4-300A-49B0-BE11-15BC7719F284Q33998494-C47CAA7C-42E1-47E4-A0E7-5283B43D3ADDQ34049557-8C37E48C-2E7C-467F-89EF-C1AA25DBC5ECQ34067951-96C1F4AE-2C12-4B70-B922-918170703FADQ34157164-DAD8F53D-A18F-4D32-B0F3-7E5F4BB97835Q34197057-FE01EC82-1235-4183-A949-D51ABDDA9293Q34202973-35F1F591-71A2-4BA3-A89B-E0A1276BFB82
P2860
Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Randomized double-blind factor ...... precancerous gastric lesions.
@en
Randomized double-blind factor ...... precancerous gastric lesions.
@nl
type
label
Randomized double-blind factor ...... precancerous gastric lesions.
@en
Randomized double-blind factor ...... precancerous gastric lesions.
@nl
prefLabel
Randomized double-blind factor ...... precancerous gastric lesions.
@en
Randomized double-blind factor ...... precancerous gastric lesions.
@nl
P2093
P2860
P356
P1476
Randomized double-blind factor ...... precancerous gastric lesions.
@en
P2093
Guang-wei Xu
Joseph F Fraumeni
Jun-ling Ma
Kai-feng Pan
Lian Zhang
Linda M Brown
Mao-lin Jin
Mitchell H Gail
P2860
P304
P356
10.1093/JNCI/DJJ264
P407
P577
2006-07-01T00:00:00Z